Table 1 Demographic information of study participants
|  | NT-ONFH patients (n = 136) | Healthy controls (n = 136) | P value |
|---|---|---|---|
Age (Y) | 53.1 ± 7.1 | 51.2 ± 6.2 | 0.242 |
Gender (F/M) | 65/71 | 67/69 | 0.703 |
BMI | 23.5 ± 2.2 | 23.0 ± 2.6 | 0.327 |
VAS score | 4.7 ± 1.5 | / |  |
HHS score | 61.0 ± 7.8 | / |  |
ARCO stage (2/3/4) | 45/47/44 | / | Â |
Etiology | Â | Â | Â |
Steriod/Alcoholic | 70/66 | / | Â |
Serum GPX4 Levels (ng/mL) | 13.02 ± 2.35 | 18.05 ± 3.30 | < 0.001 |
Serum SLC7A11 Levels (ng/mL) | 3.57 ± 1.15 | 5.52 ± 1.61 | < 0.001 |